Anti-itch Drugs - Global and China Top Players Market Share and Ranking 2023
According to the Latest Research Report,, the global market for Anti-itch Drugs should grow from US$ 3370 million in 2022 to US$ 4620.8 million by 2029, with a CAGR of 4.6% for the period of 2023-2029.
The market for anti-itch ointments is expected to grow steadily in the coming years due to several factors. First, the incidence of skin conditions that cause itchiness is increasing worldwide, largely due to environmental factors such as pollution and climate change. Additionally, an aging population is expected to drive demand for anti-itch ointments, as older adults are more likely to develop skin conditions that cause itchiness.
An antipruritic ointment is a topical medication used to relieve itching (pruritus) of the skin. It works by reducing the sensation of itching and soothing the skin.
This report studies and analyses global Anti-itch Drugs status and future trends, helps the client to determine the Anti-itch Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Anti-itch Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Anti-itch Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Anti-itch Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Anti-itch Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Anti-itch Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Anti-itch Drugs key producing regions, capacity, production, and year over year growth
(6) Anti-itch Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Johnson & Johnson
Bayer
Sanofi
Combe Incorporated
CR SANJIU
Lingrui
Jinyao Pharma
Dinuo Pharma
Huapont
Medimetriks Pharmaceuticals
Taro Pharmaceutical
Teva
Sun Pharmaceutical
Perrigo
Market segment by Type, covers
Single Preparation
Compound Ointment
Market segment by Application, can be divided into
Hospital
Pharmacy
Other
Key Regions Covered in This Report Are:
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
The Report Consists of The Following Points:
Chapter 1: to describe Anti-itch Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Anti-itch Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Anti-itch Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Anti-itch Drugs, percent & CAGR, 2018-2029
Chapter 5: Anti-itch Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Anti-itch Drugs Definition
1.2 Global Anti-itch Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Anti-itch Drugs Market Size，2018-2029
1.2.2 By Sales Quantity, Global Anti-itch Drugs Market Size，2018-2029
1.2.3 Global Anti-itch Drugs Average Selling Price (ASP)，2018-2029
1.3 China Anti-itch Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Anti-itch Drugs Market Size，2018-2029
1.3.2 By Sales Quantity, China Anti-itch Drugs Market Size，2018-2029
1.3.3 China Anti-itch Drugs Average Selling Price (ASP)， 2018-2029
1.4 Share of China Anti-itch Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Anti-itch Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Anti-itch Drugs Market Share in Global, 2018-2029
1.4.3 Anti-itch Drugs Market Size: China VS Global, 2018-2029
1.5 Anti-itch Drugs Market Dynamics
1.5.1 Anti-itch Drugs Market Drivers
1.5.2 Anti-itch Drugs Market Restraints
1.5.3 Anti-itch Drugs Industry Trends
1.5.4 Anti-itch Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Anti-itch Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Anti-itch Drugs, Global Market Share by Company, 2018-2023
2.3 Anti-itch Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Anti-itch Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Anti-itch Drugs Concentration Ratio
2.6 Global Anti-itch Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Anti-itch Drugs Manufacturers Product Type
2.8 Head Office and Anti-itch Drugs Production Site of Key Manufacturer
2.9 Anti-itch Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Anti-itch Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Anti-itch Drugs, China Market Share by Company, 2018-2023
3.3 China Anti-itch Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Anti-itch Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Anti-itch Drugs Capacity by Region
4.3 Global Anti-itch Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Anti-itch Drugs Production by Region, 2018-2029
4.5 Global Anti-itch Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Anti-itch Drugs Industry Chain
5.2 Anti-itch Drugs Upstream Analysis
5.2.1 Anti-itch Drugs Core Raw Materials
5.2.2 Main Manufacturers of Anti-itch Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Anti-itch Drugs Production Mode
5.6 Anti-itch Drugs Procurement Model
5.7 Anti-itch Drugs Industry Sales Model and Sales Channels
5.7.1 Anti-itch Drugs Sales Model
5.7.2 Anti-itch Drugs Typical Distributors
6 Sights by Type
6.1 Anti-itch Drugs Classification
6.1.1 Single Preparation
6.1.2 Compound Ointment
6.2 By Type, Global Anti-itch Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Anti-itch Drugs Consumption Value, 2018-2029
6.4 By Type, Global Anti-itch Drugs Sales Quantity, 2018-2029
6.5 By Type, Global Anti-itch Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Anti-itch Drugs Segment by Application
7.1.1 Hospital
7.1.2 Pharmacy
7.1.3 Other
7.2 By Application, Global Anti-itch Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Anti-itch Drugs Consumption Value, 2018-2029
7.4 By Application, Global Anti-itch Drugs Sales Quantity, 2018-2029
7.5 By Application, Global Anti-itch Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Anti-itch Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Anti-itch Drugs Consumption Value, 2018-2029
8.3 By Region, Global Anti-itch Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Anti-itch Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America Anti-itch Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Anti-itch Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Anti-itch Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Anti-itch Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Anti-itch Drugs Market Size Market Share
8.7 South America
8.7.1 South America Anti-itch Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Anti-itch Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Anti-itch Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Anti-itch Drugs Consumption Value, 2018-2029
9.3 By Country, Global Anti-itch Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Anti-itch Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Anti-itch Drugs Market Size, 2018-2029
9.5.2 By Type, Europe Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Anti-itch Drugs Market Size, 2018-2029
9.6.2 By Type, China Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Anti-itch Drugs Market Size, 2018-2029
9.7.2 By Type, Japan Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Anti-itch Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Anti-itch Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Anti-itch Drugs Market Size, 2018-2029
9.10.2 By Type, India Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Anti-itch Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.1.2 Johnson & Johnson Anti-itch Drugs Models, Specifications, and Application
10.1.3 Johnson & Johnson Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Johnson & Johnson Company Profile and Main Business
10.1.5 Johnson & Johnson Recent Developments
10.2 Bayer
10.2.1 Bayer Company Information, Head Office, Market Area, and Industry Position
10.2.2 Bayer Anti-itch Drugs Models, Specifications, and Application
10.2.3 Bayer Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Bayer Company Profile and Main Business
10.2.5 Bayer Recent Developments
10.3 Sanofi
10.3.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.3.2 Sanofi Anti-itch Drugs Models, Specifications, and Application
10.3.3 Sanofi Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Sanofi Company Profile and Main Business
10.3.5 Sanofi Recent Developments
10.4 Combe Incorporated
10.4.1 Combe Incorporated Company Information, Head Office, Market Area, and Industry Position
10.4.2 Combe Incorporated Anti-itch Drugs Models, Specifications, and Application
10.4.3 Combe Incorporated Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Combe Incorporated Company Profile and Main Business
10.4.5 Combe Incorporated Recent Developments
10.5 CR SANJIU
10.5.1 CR SANJIU Company Information, Head Office, Market Area, and Industry Position
10.5.2 CR SANJIU Anti-itch Drugs Models, Specifications, and Application
10.5.3 CR SANJIU Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 CR SANJIU Company Profile and Main Business
10.5.5 CR SANJIU Recent Developments
10.6 Lingrui
10.6.1 Lingrui Company Information, Head Office, Market Area, and Industry Position
10.6.2 Lingrui Anti-itch Drugs Models, Specifications, and Application
10.6.3 Lingrui Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Lingrui Company Profile and Main Business
10.6.5 Lingrui Recent Developments
10.7 Jinyao Pharma
10.7.1 Jinyao Pharma Company Information, Head Office, Market Area, and Industry Position
10.7.2 Jinyao Pharma Anti-itch Drugs Models, Specifications, and Application
10.7.3 Jinyao Pharma Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Jinyao Pharma Company Profile and Main Business
10.7.5 Jinyao Pharma Recent Developments
10.8 Dinuo Pharma
10.8.1 Dinuo Pharma Company Information, Head Office, Market Area, and Industry Position
10.8.2 Dinuo Pharma Anti-itch Drugs Models, Specifications, and Application
10.8.3 Dinuo Pharma Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Dinuo Pharma Company Profile and Main Business
10.8.5 Dinuo Pharma Recent Developments
10.9 Huapont
10.9.1 Huapont Company Information, Head Office, Market Area, and Industry Position
10.9.2 Huapont Anti-itch Drugs Models, Specifications, and Application
10.9.3 Huapont Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Huapont Company Profile and Main Business
10.9.5 Huapont Recent Developments
10.10 Medimetriks Pharmaceuticals
10.10.1 Medimetriks Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.10.2 Medimetriks Pharmaceuticals Anti-itch Drugs Models, Specifications, and Application
10.10.3 Medimetriks Pharmaceuticals Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Medimetriks Pharmaceuticals Company Profile and Main Business
10.10.5 Medimetriks Pharmaceuticals Recent Developments
10.11 Taro Pharmaceutical
10.11.1 Taro Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.11.2 Taro Pharmaceutical Anti-itch Drugs Models, Specifications, and Application
10.11.3 Taro Pharmaceutical Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Taro Pharmaceutical Company Profile and Main Business
10.11.5 Taro Pharmaceutical Recent Developments
10.12 Teva
10.12.1 Teva Company Information, Head Office, Market Area, and Industry Position
10.12.2 Teva Anti-itch Drugs Models, Specifications, and Application
10.12.3 Teva Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Teva Company Profile and Main Business
10.12.5 Teva Recent Developments
10.13 Sun Pharmaceutical
10.13.1 Sun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Sun Pharmaceutical Anti-itch Drugs Models, Specifications, and Application
10.13.3 Sun Pharmaceutical Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Sun Pharmaceutical Company Profile and Main Business
10.13.5 Sun Pharmaceutical Recent Developments
10.14 Perrigo
10.14.1 Perrigo Company Information, Head Office, Market Area, and Industry Position
10.14.2 Perrigo Anti-itch Drugs Models, Specifications, and Application
10.14.3 Perrigo Anti-itch Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Perrigo Company Profile and Main Business
10.14.5 Perrigo Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Anti-itch Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Anti-itch Drugs Market Restraints
Table 3. Anti-itch Drugs Market Trends
Table 4. Anti-itch Drugs Industry Policy
Table 5. Global Anti-itch Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Anti-itch Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Anti-itch Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Anti-itch Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Anti-itch Drugs Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Anti-itch Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Anti-itch Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Anti-itch Drugs Manufacturers Product Type
Table 13. Head Office and Anti-itch Drugs Production Site of Key Manufacturer
Table 14. Anti-itch Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China Anti-itch Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Anti-itch Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Anti-itch Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Anti-itch Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Anti-itch Drugs Production by Region, 2018-2023, (K Units)
Table 20. Global Anti-itch Drugs Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Anti-itch Drugs Upstream (Raw Materials)
Table 22. Global Anti-itch Drugs Typical Customers
Table 23. Anti-itch Drugs Typical Distributors
Table 24. By Type, Global Anti-itch Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Anti-itch Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Anti-itch Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Anti-itch Drugs Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Anti-itch Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Anti-itch Drugs Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Anti-itch Drugs Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Anti-itch Drugs Sales Quantity Market Share, 2018-2029
Table 34. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 35. Johnson & Johnson Anti-itch Drugs Models, Specifications, and Application
Table 36. Johnson & Johnson Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Johnson & Johnson Company Profile and Main Business
Table 38. Johnson & Johnson Recent Developments
Table 39. Bayer Company Information, Head Office, Market Area, and Industry Position
Table 40. Bayer Anti-itch Drugs Models, Specifications, and Application
Table 41. Bayer Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Bayer Company Profile and Main Business
Table 43. Bayer Recent Developments
Table 44. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 45. Sanofi Anti-itch Drugs Models, Specifications, and Application
Table 46. Sanofi Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sanofi Company Profile and Main Business
Table 48. Sanofi Recent Developments
Table 49. Combe Incorporated Company Information, Head Office, Market Area, and Industry Position
Table 50. Combe Incorporated Anti-itch Drugs Models, Specifications, and Application
Table 51. Combe Incorporated Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Combe Incorporated Company Profile and Main Business
Table 53. Combe Incorporated Recent Developments
Table 54. CR SANJIU Company Information, Head Office, Market Area, and Industry Position
Table 55. CR SANJIU Anti-itch Drugs Models, Specifications, and Application
Table 56. CR SANJIU Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. CR SANJIU Company Profile and Main Business
Table 58. CR SANJIU Recent Developments
Table 59. Lingrui Company Information, Head Office, Market Area, and Industry Position
Table 60. Lingrui Anti-itch Drugs Models, Specifications, and Application
Table 61. Lingrui Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Lingrui Company Profile and Main Business
Table 63. Lingrui Recent Developments
Table 64. Jinyao Pharma Company Information, Head Office, Market Area, and Industry Position
Table 65. Jinyao Pharma Anti-itch Drugs Models, Specifications, and Application
Table 66. Jinyao Pharma Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Jinyao Pharma Company Profile and Main Business
Table 68. Jinyao Pharma Recent Developments
Table 69. Dinuo Pharma Company Information, Head Office, Market Area, and Industry Position
Table 70. Dinuo Pharma Anti-itch Drugs Models, Specifications, and Application
Table 71. Dinuo Pharma Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Dinuo Pharma Company Profile and Main Business
Table 73. Dinuo Pharma Recent Developments
Table 74. Huapont Company Information, Head Office, Market Area, and Industry Position
Table 75. Huapont Anti-itch Drugs Models, Specifications, and Application
Table 76. Huapont Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Huapont Company Profile and Main Business
Table 78. Huapont Recent Developments
Table 79. Medimetriks Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 80. Medimetriks Pharmaceuticals Anti-itch Drugs Models, Specifications, and Application
Table 81. Medimetriks Pharmaceuticals Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Medimetriks Pharmaceuticals Company Profile and Main Business
Table 83. Medimetriks Pharmaceuticals Recent Developments
Table 84. Taro Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 85. Taro Pharmaceutical Anti-itch Drugs Models, Specifications, and Application
Table 86. Taro Pharmaceutical Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Taro Pharmaceutical Company Profile and Main Business
Table 88. Taro Pharmaceutical Recent Developments
Table 89. Teva Company Information, Head Office, Market Area, and Industry Position
Table 90. Teva Anti-itch Drugs Models, Specifications, and Application
Table 91. Teva Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Teva Company Profile and Main Business
Table 93. Teva Recent Developments
Table 94. Sun Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
Table 95. Sun Pharmaceutical Anti-itch Drugs Models, Specifications, and Application
Table 96. Sun Pharmaceutical Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Sun Pharmaceutical Company Profile and Main Business
Table 98. Sun Pharmaceutical Recent Developments
Table 99. Perrigo Company Information, Head Office, Market Area, and Industry Position
Table 100. Perrigo Anti-itch Drugs Models, Specifications, and Application
Table 101. Perrigo Anti-itch Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Perrigo Company Profile and Main Business
Table 103. Perrigo Recent Developments
List of Figures
Figure 1. Anti-itch Drugs Picture
Figure 2. Global Anti-itch Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Anti-itch Drugs Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Anti-itch Drugs Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Anti-itch Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Anti-itch Drugs Sales Quantity (K Units) & (2018-2029)
Figure 7. China Anti-itch Drugs Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Anti-itch Drugs Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Anti-itch Drugs Market Share of Global, 2018-2029
Figure 10. Global Anti-itch Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Anti-itch Drugs Key Participants, Market Share, 2022
Figure 12. Global Anti-itch Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Anti-itch Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Anti-itch Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 15. Anti-itch Drugs Industry Chain
Figure 16. Anti-itch Drugs Procurement Model
Figure 17. Anti-itch Drugs Sales Model
Figure 18. Anti-itch Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Single Preparation
Figure 20. Compound Ointment
Figure 21. By Type, Global Anti-itch Drugs Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Anti-itch Drugs Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Anti-itch Drugs Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Anti-itch Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Hospital
Figure 27. Pharmacy
Figure 28. Other
Figure 29. By Application, Global Anti-itch Drugs Consumption Value, 2018-2029, US$ Million
Figure 30. By Application, Global Anti-itch Drugs Consumption Value Market Share, 2018-2029
Figure 31. By Application, Global Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 32. By Application, Global Anti-itch Drugs Sales Quantity Market Share, 2018-2029
Figure 33. By Application, Global Anti-itch Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Anti-itch Drugs Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Anti-itch Drugs Sales Quantity Market Share, 2018-2029
Figure 36. North America Anti-itch Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Anti-itch Drugs Consumption Value Market Share, 2022
Figure 38. Europe Anti-itch Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Anti-itch Drugs Consumption Value Market Share, 2022
Figure 40. Asia Pacific Anti-itch Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Anti-itch Drugs Consumption Value Market Share, 2022
Figure 42. South America Anti-itch Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Anti-itch Drugs Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Anti-itch Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 46. By Type, U.S. Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Application, U.S. Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, Europe Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, Europe Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, China Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, China Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, Japan Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Japan Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, South Korea Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, South Korea Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, Southeast Asia Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Southeast Asia Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, India Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, India Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Anti-itch Drugs Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, Middle East & Africa Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Middle East & Africa Anti-itch Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|